Author:
Wyska Elżbieta,Świerczek Artur,Pociecha Krzysztof,Przejczowska-Pomierny Katarzyna
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference39 articles.
1. Abraham E, Bursten S, Shenkar R, Allbee J, Tuder R, Woodson P, Guidot DM, Rice G, Singer JW, Repine JE (1995) Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J Exp Med 181:569–575
2. ARDS Clinical Trials Network, National Heart, Lung, and Blood Institute, National Institutes of Health (2002) Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 30:1–6
3. Bleich D, Chen S, Bursten SL, Nadler JL (1996) Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets. Endocrinology 137:4871–4877
4. Bogaards JJ, Bertrand M, Jackson F, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B (2000) Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:1131–1152
5. Bright JJ, Du C, Coon M, Sriram S, Klaus SJ (1998) Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J Immunol 161:7015–7022
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献